Copyright Reports & Markets. All rights reserved.

Global Cystic Fibrosis Treatment Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Cystic Fibrosis Treatment Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Cystic Fibrosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Oral
    • 1.4.3 Injection
  • 1.5 Market by Application
    • 1.5.1 Global Cystic Fibrosis Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Cystic Fibrosis Treatment Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Cystic Fibrosis Treatment Industry
      • 1.6.1.1 Cystic Fibrosis Treatment Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Cystic Fibrosis Treatment Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Cystic Fibrosis Treatment Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Cystic Fibrosis Treatment Market Perspective (2015-2026)
  • 2.2 Cystic Fibrosis Treatment Growth Trends by Regions
    • 2.2.1 Cystic Fibrosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cystic Fibrosis Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cystic Fibrosis Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Cystic Fibrosis Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Cystic Fibrosis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Cystic Fibrosis Treatment Players by Market Size
    • 3.1.1 Global Top Cystic Fibrosis Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Cystic Fibrosis Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Cystic Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Cystic Fibrosis Treatment Market Concentration Ratio
    • 3.2.1 Global Cystic Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Treatment Revenue in 2019
  • 3.3 Cystic Fibrosis Treatment Key Players Head office and Area Served
  • 3.4 Key Players Cystic Fibrosis Treatment Product Solution and Service
  • 3.5 Date of Enter into Cystic Fibrosis Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Cystic Fibrosis Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Cystic Fibrosis Treatment Forecasted Market Size by Type (2021-2026)

5 Cystic Fibrosis Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Cystic Fibrosis Treatment Market Size by Application (2015-2020)
  • 5.2 Global Cystic Fibrosis Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cystic Fibrosis Treatment Market Size (2015-2020)
  • 6.2 Cystic Fibrosis Treatment Key Players in North America (2019-2020)
  • 6.3 North America Cystic Fibrosis Treatment Market Size by Type (2015-2020)
  • 6.4 North America Cystic Fibrosis Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Cystic Fibrosis Treatment Market Size (2015-2020)
  • 7.2 Cystic Fibrosis Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Cystic Fibrosis Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Cystic Fibrosis Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Cystic Fibrosis Treatment Market Size (2015-2020)
  • 8.2 Cystic Fibrosis Treatment Key Players in China (2019-2020)
  • 8.3 China Cystic Fibrosis Treatment Market Size by Type (2015-2020)
  • 8.4 China Cystic Fibrosis Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Cystic Fibrosis Treatment Market Size (2015-2020)
  • 9.2 Cystic Fibrosis Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Cystic Fibrosis Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Cystic Fibrosis Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Cystic Fibrosis Treatment Market Size (2015-2020)
  • 10.2 Cystic Fibrosis Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Cystic Fibrosis Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Cystic Fibrosis Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Cystic Fibrosis Treatment Market Size (2015-2020)
  • 11.2 Cystic Fibrosis Treatment Key Players in India (2019-2020)
  • 11.3 India Cystic Fibrosis Treatment Market Size by Type (2015-2020)
  • 11.4 India Cystic Fibrosis Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Cystic Fibrosis Treatment Market Size (2015-2020)
  • 12.2 Cystic Fibrosis Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Cystic Fibrosis Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Cystic Fibrosis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Actavis
    • 13.1.1 Actavis Company Details
    • 13.1.2 Actavis Business Overview and Its Total Revenue
    • 13.1.3 Actavis Cystic Fibrosis Treatment Introduction
    • 13.1.4 Actavis Revenue in Cystic Fibrosis Treatment Business (2015-2020))
    • 13.1.5 Actavis Recent Development
  • 13.2 F. Hoffmann-La Roche
    • 13.2.1 F. Hoffmann-La Roche Company Details
    • 13.2.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
    • 13.2.3 F. Hoffmann-La Roche Cystic Fibrosis Treatment Introduction
    • 13.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.2.5 F. Hoffmann-La Roche Recent Development
  • 13.3 Gilead Sciences
    • 13.3.1 Gilead Sciences Company Details
    • 13.3.2 Gilead Sciences Business Overview and Its Total Revenue
    • 13.3.3 Gilead Sciences Cystic Fibrosis Treatment Introduction
    • 13.3.4 Gilead Sciences Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.3.5 Gilead Sciences Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview and Its Total Revenue
    • 13.4.3 Novartis Cystic Fibrosis Treatment Introduction
    • 13.4.4 Novartis Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 Vertex Pharmaceuticals
    • 13.5.1 Vertex Pharmaceuticals Company Details
    • 13.5.2 Vertex Pharmaceuticals Business Overview and Its Total Revenue
    • 13.5.3 Vertex Pharmaceuticals Cystic Fibrosis Treatment Introduction
    • 13.5.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.5.5 Vertex Pharmaceuticals Recent Development
  • 13.6 Abbott
    • 13.6.1 Abbott Company Details
    • 13.6.2 Abbott Business Overview and Its Total Revenue
    • 13.6.3 Abbott Cystic Fibrosis Treatment Introduction
    • 13.6.4 Abbott Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.6.5 Abbott Recent Development
  • 13.7 Anthera Pharmaceuticals
    • 13.7.1 Anthera Pharmaceuticals Company Details
    • 13.7.2 Anthera Pharmaceuticals Business Overview and Its Total Revenue
    • 13.7.3 Anthera Pharmaceuticals Cystic Fibrosis Treatment Introduction
    • 13.7.4 Anthera Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.7.5 Anthera Pharmaceuticals Recent Development
  • 13.8 Arcturus Therapeutics
    • 13.8.1 Arcturus Therapeutics Company Details
    • 13.8.2 Arcturus Therapeutics Business Overview and Its Total Revenue
    • 13.8.3 Arcturus Therapeutics Cystic Fibrosis Treatment Introduction
    • 13.8.4 Arcturus Therapeutics Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.8.5 Arcturus Therapeutics Recent Development
  • 13.9 Boehringer Ingelheim
    • 13.9.1 Boehringer Ingelheim Company Details
    • 13.9.2 Boehringer Ingelheim Business Overview and Its Total Revenue
    • 13.9.3 Boehringer Ingelheim Cystic Fibrosis Treatment Introduction
    • 13.9.4 Boehringer Ingelheim Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.9.5 Boehringer Ingelheim Recent Development
  • 13.10 Chiesi Farmaceutici
    • 13.10.1 Chiesi Farmaceutici Company Details
    • 13.10.2 Chiesi Farmaceutici Business Overview and Its Total Revenue
    • 13.10.3 Chiesi Farmaceutici Cystic Fibrosis Treatment Introduction
    • 13.10.4 Chiesi Farmaceutici Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 13.10.5 Chiesi Farmaceutici Recent Development
  • 13.11 Corbus Pharmaceuticals
    • 10.11.1 Corbus Pharmaceuticals Company Details
    • 10.11.2 Corbus Pharmaceuticals Business Overview and Its Total Revenue
    • 10.11.3 Corbus Pharmaceuticals Cystic Fibrosis Treatment Introduction
    • 10.11.4 Corbus Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.11.5 Corbus Pharmaceuticals Recent Development
  • 13.12 Genzyme
    • 10.12.1 Genzyme Company Details
    • 10.12.2 Genzyme Business Overview and Its Total Revenue
    • 10.12.3 Genzyme Cystic Fibrosis Treatment Introduction
    • 10.12.4 Genzyme Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.12.5 Genzyme Recent Development
  • 13.13 Insmed
    • 10.13.1 Insmed Company Details
    • 10.13.2 Insmed Business Overview and Its Total Revenue
    • 10.13.3 Insmed Cystic Fibrosis Treatment Introduction
    • 10.13.4 Insmed Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.13.5 Insmed Recent Development
  • 13.14 Johnson & Johnson
    • 10.14.1 Johnson & Johnson Company Details
    • 10.14.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 10.14.3 Johnson & Johnson Cystic Fibrosis Treatment Introduction
    • 10.14.4 Johnson & Johnson Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.14.5 Johnson & Johnson Recent Development
  • 13.15 Merck Sharp & Dohme
    • 10.15.1 Merck Sharp & Dohme Company Details
    • 10.15.2 Merck Sharp & Dohme Business Overview and Its Total Revenue
    • 10.15.3 Merck Sharp & Dohme Cystic Fibrosis Treatment Introduction
    • 10.15.4 Merck Sharp & Dohme Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.15.5 Merck Sharp & Dohme Recent Development
  • 13.16 Neovii Biotech
    • 10.16.1 Neovii Biotech Company Details
    • 10.16.2 Neovii Biotech Business Overview and Its Total Revenue
    • 10.16.3 Neovii Biotech Cystic Fibrosis Treatment Introduction
    • 10.16.4 Neovii Biotech Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.16.5 Neovii Biotech Recent Development
  • 13.17 Novo Nordisk
    • 10.17.1 Novo Nordisk Company Details
    • 10.17.2 Novo Nordisk Business Overview and Its Total Revenue
    • 10.17.3 Novo Nordisk Cystic Fibrosis Treatment Introduction
    • 10.17.4 Novo Nordisk Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.17.5 Novo Nordisk Recent Development
  • 13.18 PharmaSwiss
    • 10.18.1 PharmaSwiss Company Details
    • 10.18.2 PharmaSwiss Business Overview and Its Total Revenue
    • 10.18.3 PharmaSwiss Cystic Fibrosis Treatment Introduction
    • 10.18.4 PharmaSwiss Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.18.5 PharmaSwiss Recent Development
  • 13.19 Pharmaxis
    • 10.19.1 Pharmaxis Company Details
    • 10.19.2 Pharmaxis Business Overview and Its Total Revenue
    • 10.19.3 Pharmaxis Cystic Fibrosis Treatment Introduction
    • 10.19.4 Pharmaxis Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.19.5 Pharmaxis Recent Development
  • 13.20 Proteostasis Therapeutics
    • 10.20.1 Proteostasis Therapeutics Company Details
    • 10.20.2 Proteostasis Therapeutics Business Overview and Its Total Revenue
    • 10.20.3 Proteostasis Therapeutics Cystic Fibrosis Treatment Introduction
    • 10.20.4 Proteostasis Therapeutics Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.20.5 Proteostasis Therapeutics Recent Development
  • 13.21 PTC Therapeutics
    • 10.21.1 PTC Therapeutics Company Details
    • 10.21.2 PTC Therapeutics Business Overview and Its Total Revenue
    • 10.21.3 PTC Therapeutics Cystic Fibrosis Treatment Introduction
    • 10.21.4 PTC Therapeutics Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.21.5 PTC Therapeutics Recent Development
  • 13.22 United Medical
    • 10.22.1 United Medical Company Details
    • 10.22.2 United Medical Business Overview and Its Total Revenue
    • 10.22.3 United Medical Cystic Fibrosis Treatment Introduction
    • 10.22.4 United Medical Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.22.5 United Medical Recent Development
  • 13.23 Venus Remedies
    • 10.23.1 Venus Remedies Company Details
    • 10.23.2 Venus Remedies Business Overview and Its Total Revenue
    • 10.23.3 Venus Remedies Cystic Fibrosis Treatment Introduction
    • 10.23.4 Venus Remedies Revenue in Cystic Fibrosis Treatment Business (2015-2020)
    • 10.23.5 Venus Remedies Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Cystic Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cystic Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Actavis
    F. Hoffmann-La Roche
    Gilead Sciences
    Novartis
    Vertex Pharmaceuticals
    Abbott
    Anthera Pharmaceuticals
    Arcturus Therapeutics
    Boehringer Ingelheim
    Chiesi Farmaceutici
    Corbus Pharmaceuticals
    Genzyme
    Insmed
    Johnson & Johnson
    Merck Sharp & Dohme
    Neovii Biotech
    Novo Nordisk
    PharmaSwiss
    Pharmaxis
    Proteostasis Therapeutics
    PTC Therapeutics
    United Medical
    Venus Remedies

    Market segment by Type, the product can be split into
    Oral
    Injection
    Market segment by Application, split into
    Hospitals
    Clinics
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Cystic Fibrosis Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Cystic Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Cystic Fibrosis Treatment are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now